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Summary The epidemiology of germ cell cancer of the ovary has been little investigated. We studied ovarian
germ cell cancers incident 1971-84 in England, using data from the England and Wales national cancer
register. The age distribution showed a sharp peak at ages 15-19, to which both teratomas and dysgermin-
omas contributed equally, and a secondary, much wider peak, at ages 65-69, mainly due to teratomas. For
teratomas there were diverging secular trends by age: incidence has been increasing at ages 0-44 (P around
0.05) and decreasing at ages over 44 (P<0.01). Birth cohort analysis showed an increase in risk at ages 0-44
for more recent generations of women. There were no changes over time for dysgerminomas. There was no
clear geographic pattern of distribution across the regions of England. The early age peak, and the increase in
incidence of ovarian germ cell cancers at young ages but decrease at older ages, resembles testicular cancer
epidemiology. Interestingly, discrepancies and similarities in the age distribution of these tumours between the
sexes parallel lifetime profiles of gonadotropin levels in each sex.
Germ cell cancers comprise a small proportion of all ovarian
cancers (Weiss et al., 1977) whereas the corresponding
tumours in males account for almost all testicular cancers
(Pike et al., 1987). Probably as a consequence, whilst there
are many population-based studies on the epidemiology of
testis cancer, there is very little information available for its
ovarian counterpart. To our knowledge, only one popula-
tion-based study (Walker et al., 1984) has assessed the time
trends of these rare tumours, and then only for a short
period and from a relatively small catchment population.
Early exposures in life, particularly oestrogen exposures in
utero, have recently been investigated as potential risk factors
for ovarian germ cell malignancies (Walker et al., 1988). This
pre-natal oestrogen hypothesis was first raised for germ cell
tumours of the testis (Henderson et al., 1979; Loughlin et al.,
1980; Schottenfeld et al., 1980; Depue et al., 1983) and later,
extended to ovarian germ cell cancer on the assumption that
if they have the same histogenesis (Fox, 1980) and similar
early age peaks (Walker et al., 1984), they may share at least
some aetiological factors.
The England and Wales national cancer registry holds an
exceptionally large cancer dataset from a catchment popula-
tion of about 50 million. Tumours are coded in its files
according to both site and histology (Swerdlow, 1986),
although the data appear not to have been used previously
for national analyses of cancer by histology. We used data
from this registry to assess the epidemiological features of
this female cancer and to draw comparisons which might
shed light on the epidemiology of testicular cancer, the most
common malignancy in young men (Davies, 1981).
Material and methods
Cancer registration data in England and Wales are collected
by regional registries. From the clinical notes, pathology
records and various other sources, they extract information
on the characteristics of the tumour, including its histology.
Data are then sent to the national cancer registry at the
Office of Population Censuses and Surveys (OPCS) who col-
late, analyse and publish them. Further details are given
elsewhere (Swerdlow, 1986).
From the OPCS files, we extracted all cancer registrations
incident 1971-84 whose primary site of malignancy was
allocated to ovary (International Classification of Diseases
code 183.0) (World Health Organization, 1967, 1978) and
whose histology was reported to be of germ cell nature.
Tumour histology was coded according to the Manual of
Tumour Nomenclature and Coding (MOTNAC) (American
Cancer Society, 1968) for 1971-78 data and the Interna-
tional Classification of Diseases for Oncology (ICD-O)
(World Health Organization, 1976) for data from 1979 on-
wards. The present analysis was restricted to 1971 onwards,
because the histological code used before then, a two-digit
OPCS code, was very elementary. The analyses were all
restricted to England, because ofincompleteness in the Welsh
data, as explained under 'Results'. We also extracted from
the OPCS files: (1) tabulations of ovarian cancer registrations
incident 1971-84 by histology and (2) mid-year population
estimates of England and its hospital regions for 1971-84.
Tabulations of testicular cancer (ICD: 186) registrations inci-
dent 1971-84 by hospital region of residence were taken
from published sources (Office of Population Censuses and
Surveys, 1979-1988).
Since data on histological type were incomplete in the
OPCS files, the observed numbers of ovarian cancers with
germ cell histology in the files were an underestimation of the
true numbers of incident cases and the extent of this under-
estimation will vary by region and time. We therefore esti-
mated the true numbers by multiplying, in each year of
registration, region and 5-year age-group category, the
observed number of registrations by the inverse of the corre-
sponding proportion of ovarian cancers with histological
confirmation. The analyses were executed both on the unad-
justed data and on the estimated true incident numbers, but
since they showed similar trends the results given here refer
to the adjusted data unless otherwise specified.
Analyses were carried out for ovarian germ cell cancers
overall and separately for its two major histological cate-
gories, dysgerminomas and teratomas. Both embryonal and
extra-embryonal cell types (i.e. embryonal cell carcinoma,
endodermal sinus tumour and choriocarcinoma) were includ-
ed in the latter category (Fox, 1980). Directly age-standard-
ised rates were calculated using the 1978 female mid-year
population of England as the standard.
To assess secular trends of incidence, we fitted a Poisson
regression model (Breslow & Day, 1987). Estimated numbers
of incident cases were truncated to whole numbers before the
model was fitted. Due to small numbers, time trends in
specific age-groups (0-14, 15-24, ..., 65-74, 75+) were
analysed by splitting the 14-year study period into three
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calendar periods: 1971-75, 1976-80 and 1981-84; statistical
significance of trends was assessed by the Mantel-Haenszel
chi-square test (Breslow & Day, 1980).
To examine risks according to birth cohort, standardised
cohort registration ratios (SCRRs) were calculated (Beral et
al., 1978), again using the female 1978 mid-year population
as the standard. The SCRR summarises by direct standardis-
ation the cumulative risk experience of each successive gener-
ation of women relative to the overall risk for all women;
age-specific comparisons are cumulated up to the age which a
particular generation has reached at the end of the analysis
period. An SCRR of 120, for instance, would indicate that
the risk for that particular generation was 20% above the
average for all women of England in the analysis, whereas an
SCRR of 80 would indicate that the risk was 20% below.
Exact year of birth, which was known for all cases, was used
in the cohort analysis. Since data on population by year of
birth were not available, these were estimated from OPCS
statistics on the population by calendar year and single year
of age; for each age versus calendar year combination in
these statistics, two adjacent years of birth were possible, and
we assumed that the populations were born equally in these 2
years.
Geographical distribution was analysed by hospital region
of residence for the study years aggregated; there were minor
regional boundary changes in 1974, but their effect should
have been negligible for the present analysis. For com-
parison, the geographical distribution of testicular cancer was
also analysed for the same period. The significance of region-
al incidence rates compared to national rates was tested using
the significance factors of a Poisson distribution (Bailar &
Ederer, 1964). The 95% confidence intervals were slightly
conservative since estimated numbers with decimal figures
were truncated.
All calculations were carried out in the EPILOG statistical
software package (EPICENTER SOFTWARE, 1985).
Results
Table I shows percentages of ovarian tumours with histology
known by region and age. There was virtually no change
over time in the percentage confirmed for England overall,
although some individual regions showed increases or
decreases. The proportion known was greatest at younger
ages: at 0-44 almost 90% were known nationally, and over
80% were known in all but three regions. At older ages the
proportion decreased: at ages 65 and above, around 60%
were known nationally and in most but not all regions.
Wales had a very low proportion of ovarian cancers with
known histology (20%), and for this reason was excluded
entirely from the present study. We also excluded from the
analyses three registrations (0.53%) with unknown hospital
region of residence, leaving a total of 558 incident cases.
Table I Proportions of registered ovarian cancers with histology
known, by region and age, England 1971-84
Age (years)
Region 0-44 45-64 65 + All ages
Northern 82.8 81.5 62.8 73.83
York 86.5 79.9 62.7 73.08
Trent 75.2 67.1 48.7 60.24
E Anglia 84.2 79.2 61.7 71.61
NW Thames 81.6 72.0 56.8 66.52
NE Thames 72.6 60.8 44.9 54.61
SE Thames 87.4 82.6 64.1 74.07
SW Thames 86.2 83.4 67.5 76.02
Wessex 52.8 46.9 37.7 43.30
Oxford 86.5 86.0 74.8 81.32
S Western 81.9 75.7 61.6 69.52
W Midlands 85.8 82.0 66.1 76.12
N Western 87.9 76.8 59.6 69.74
Mersey 88.5 77.7 60.5 71.40
England 88.5 77.7 60.5 68.71
These represented 1.4% of all ovarian cancers of known
histology registered from the same population. Teratomas
comprised 63.8% (356) of these tumours and dysgerminomas
36.2% (202).
The age distribution of ovarian germ cell cancer for the
study period (Figure 1) showed an early sharp peak at ages
15-19, to which both histologies contributed equally, and a
later, but broader peak at ages 65-69, mainly due to tera-
tomas. Analysis by single year (Table II) showed that tera-
tomas peaked slightly earlier (at age 17) than dysgerminomas
(at age 19).
Secular trends in incidence of ovarian germ cell cancer by
cell type and age are shown in Figures 2 and 3. There was no
significant linear trend for germ cell cancer overall (b = 0.024,
P = 0.80) in England (Figure 2b) or any of the regions
examined separately (not shown in Figure), although there
was some decrease in incidence rates since 1979. Again, no
significant trend emerged when analysis was subdivided by
cell type (Figure 2b) (teratomas: b = -0.006, P = 0.61; dys-
germinomas: b = 0.002, P = 0.90). However, analyses by age
and histology showed that there were diverging time trends
in teratoma incidence for young and for older women
(Figure 3): at ages under 45, there was a significant increase
in incidence (b = 0.035, P = 0.04), whereas at ages 45 and
over there was a significant decrease (b = -0.053, P = 0.003).
Dysgerminoma rates have remained constant over time in
both age-groups (at 0-44 years, b = -0.006, P = 0.76; at
45 + years, b = - 0.082, P = 0.31). Ovarian germ cell cancer
overall showed similar diverging trends by age to teratomas,
but only significant in older women (b = -0.04; P = 0.01).
There was no correlation between teratoma and dysger-
minoma rates by year (r = 0.10, P = 0.74).
Further breakdown by age, showed that the increase in
teratoma incidence occurred across all groups under age 45
and the decrease across all groups older than this; the trends
were significant only at ages 55-64 (x2, = 3.88; P = 0.048)
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Figure 1 Age distribution of ovarian germ cell cancer in Eng-
land. Mean annual registration rates for 1971-84.
Table II Age distribution of ovarian germ cell cancers of known
histology, England 1971-84
Teratomas Dysgerminomas Teratomas Dysgerminomas
Age Rate* (No) Rate* (No) Age Rate* (No) Rate* (No)
0- 0.00 (0) 0.00 (0) 13- 1.29 (8) 1.29 (8)
1- 0.53 (2) 0.00 (0) 14- 2.15 (10) 0.43 (2)
2- 0.26 (1) 0.00 (0) 15- 1.51 (7) 1.51 (7)
3- 0.19 (1) 0.00 (0) 16- 1.52 (7) 1.51 (7)
4- 0.25 (1) 0.00(0) 17- 2.62(12) 2.19 (10)
5- 0.00 (0) 0.00 (0) 18- 2.14 (13) 2.14 (13)
6- 0.00 (0) 0.00 (0) 19- 1.78 (8) 2.45 (11)
7- 0.47 (2) 0.24 (1) 20- 1.58 (7) 2.25 (10)
8- 0.00 (0) 0.16 (1) 21- 1.60 (7) 1.60 (7)
9- 1.12 (5) 0.45 (2) 22- 1.38 (6) 1.15 (5)
10- 0.66 (3) 1.32 (6) 23- 1.15 (7) 1.98 (12)
11- 1.30 (6) 1.08 (5) 24- 0.70 (3) 1.63 (7)
12 0.86 (4) 1.50 (7) 25- 1.15 (5) 1.61 (7)
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Figure 2 Secular trends in ovarian germ cell cancer incidence by
cell type, England, 1971-84 (annual age-standardised rates):
before a and after b adjustment for cases of unknown histology
(see text).
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Figure 4 Incidence trends by birth cohort of ovarian germ
cancer among women aged 0-44 years born 1935-1969, Eng-
land.
lysis showed similar cohort trends (for ages under 45, all
germ cell cancers: b = 2.99, P = 0.03; teratomas: b = 5.48,
P = 0.03).
Analysis by hospital region of residence age 0-44 years did
not show any clear geographic pattern: East Anglia and
Trent had the highest rates (3.47 and 2.89 per million per
annum, respectively), but only significantly raised compared
to England for the former region (P<0.05). There was also
no correlation between teratoma and dysgerminoma risk over
the regions of England (r = 0.12, P = 0.69), nor between
ovarian germ cell cancer overall (r = 0.27, P = 0.35) or any
of its cell types and testicular cancer risk across regions. The
same picture emerged from repitition of these analyses with
the unadjusted data.
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Figure 3 Secular trends and linear regression lines of ovarian
malignant teratomas by age, England, 1971-84 (annual age-
standardised rates).
and 75 and over (x2, = 5.22; P = 0.02). Dysgerminomas
showed an irregular pattern across theAdifferent age-groups;
there was a significant increase in incidence at ages 55-64
(X21 = 4.84; P = 0.03) but based on small numbers (one case
in 1971-75). The above analyses were adjusted for cases of
histology not known, but repetition using only actual
numbers of cases with histology known gave similar results
(Figure 2a): teratomas showed diverging trends, although
only significant in older women (ages 0-44: b = 0.031, P =
0.07; ages 45+: b = - 0.047, P = 0.01).
Analysis by birth cohort (Figure 4) showed a slight in-
crease in risk of ovarian germ cell cancer before age 45 years
for the most recent generations of women (b = 2.93, P=
0.01), particularly for teratomas (b = 5.57, P = 0.01); there
was no change for dysgerminomas. The risk in women aged
45 and above remained constant. Again, the unadjusted ana-
Our data suggested that ovarian germ cell malignancies com-
prise two different epidemiological entities: the first occurring
at young ages and the second at older ages, with a division at
around 45 years. The young peak, a typical feature of these
tumours, was formed equally by dysgerminomas and tera-
tomas; in our data the peak was slightly younger for
teratomas than dysgerminomas, as in other populations
(Stalsberg et al., 1983; Walker et al., 1984). The peak at older
ages was largely formed by teratomas, being much more
prominent in the present data than in Los Angeles (Walker et
al., 1984), but similar to that reported from several countries
by Stalsberg et al. (1983) and the US Third National Cancer
Survey 1969-71 (Weiss et al., 1977). The early age peak of
ovarian germ cell malignancies resembles that of testicular
germ cell cancer, except that it occurs about 10 years earlier;
as seen in females, teratomas in males peak earlier than
seminomas (the equivalent of dysgerminomas in females)
(Walker et al., 1984; Pike et al., 1987). Testicular cancer has
a small peak in children under 5 years, although only in part
of germ cell origin (Pike et al., 1987); our data were insuffi-
cient to examine the distribution in childhood (only five cases
occurred under age 5 years) but data from the Oxford Child-
hood Cancer Survey, a larger dataset from all Britain, sug-
gest that there may well be a peak around age 2 (G.J.
Draper, personal communication). The peak at older ages for
ovarian cancer has no counterpart in males: there is a rise in
incidence of cancer of the testis at older ages, but it is not of
germ cell histology (Pike et al., 1987).
Time trends in ovarian germ cell cancer were different for
the two main age-groups, resulting from differences for tera-
tomas: a rise in incidence was observed in young women,
although only statistically significant for the adjusted data,
and a decline in older women. Analysis by birth cohort also
implied an increasing risk for more recent generations of
women aged 0-44. The observed SCRRs were more accurate
than usual; use of exact year of birth avoided the overlap
between adjacent generations which occurs with the conven-
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tional method of Case (1956). Since the overall, all-years,
data had to be used to calculate the expected values, the ratio
of observed to expected will tend to have been conservatively
biased, particularly in the earliest and latest cohorts, and
therefore real changes might have been underestimated.
Interpretation should also take into account that the number
of cases by year of birth was small, particularly for dysger-
minomas, and that the experience for the most recent genera-
tions was based only on the (young) age-groups that they
have yet reached. Walker et al. (1984) also reported an
increasing secular trend in ovarian germ cell cancer in young
women (although mainly in dysgerminomas) and no signifi-
cant changes at older ages, but their analyses were based on
very few cases. This contrasts with a relatively constant
mortality from these tumours observed during the fifties and
sixties in the United States (Li et al., 1973). An increase in
incidence at young ages and a decrease at older ages with
cohort effects underlying them has been shown in males for
testicular cancer (Davies, 1981; Osterlind, 1986).
Potential artifacts need to be considered. Completeness of
cancer registration in England has probably improved over
time (Swerdlow, 1986), but this seems unlikely to have dis-
torted the results since the regional analyses showed results
for registries whose completeness appears to have been very
high throughout the period similar to those observed for
England overall. Potential late registrations, yet to be entered
onto the OPCS data files, are likely to have been ofnegligible
effect since the analyses were conducted only to 1984, 7 years
ago. The decrease in rates since 1979, in particular, is
unlikely to be due to this, since we have calculated rates for
ovarian cancer overall and they do not show any downward
trend in recent years.
Incompleteness of histological confirmation seems unlikely
to explain the results since the proportion of ovarian cancers
with unknown histology was small at younger ages, when
most of the tumours occurred, and the results were similar
when restricted to tumours of known histology. Lack of
uniform criteria among pathologists, and potential changes in
diagnostic criteria over time, might have affected the results;
in particular, the adjustment made for cases of unknown
histology depends on the assumption that the proportions
with histology known for germ cell tumours were the same as
those for all ovarian cancers, which might not have been the
case. Since most of the tumours occurred at young ages they
were, however, more likely to be properly diagnosed. Besides,
the age distribution curves from the present data were similar
to those from other registry-based studies in which histology
was specially reviewed (Stalsberg et al., 1983).
The age distribution of ovarian germ cell malignancies did
not parallel gonadal activity: although the rise in incidence
from pubertal to young adult ages occurred at a time of
increase in ovarian activity, the decrease observed thereafter
occurred when the ovaries are functionally highly active, and
the peak at older ages when their activity is greatly reduced.
There are parallels however between germ cell cancer inci-
dence and gonadotrophic hormone levels (follicular stimulat-
ing hormone (FSH) and luteinising hormone (LH)). These
hormones are known to promote the multiplication of ovar-
ian germ cells (Henderson et al., 1982). In both sexes, there is
a rise in the baseline plasma levels of gonadotrophins at
prepubertal ages, just before the occurrence of the young age
peak in germ cell cancer, followed by a decline after puberty
(Coble et al., 1969; Baker et al., 1976). At a later stage, due
to loss of negative feedback from ovarian hormones, the
onset of the menopause is accompanied by a 15-fold increase
in the production of FSH and a 5-fold increase in the
production of LH (Coble et al., 1969; Cooke et al., 1976), a
situation that has no parallel in males, in whom gonado-
tropin levels rise only slightly after the sixth decade of life
(Baker et al., 1976). These sex differences in gonadotropin
stimulation might be responsible for the sex discrepancy in
the age distribution ofthese tumours, namely, the presence of
the second later peak in females and not in males. Also, the
fact that the young peak occurred earlier in females than
males might in part be due to an earlier mean age ofpuberty
in females (Marshall & Tanner, 1970) (although a shorter
induction period after puberty would also need to be postu-
lated to explain the full extent of the difference). High levels
of plasma gonadotropins, greater even than at prepubertal
ages, are present in both sexes in the first 2 years of life,
decreasing thereafter (Faiman & Winter, 1971; Forest et al.,
1974). This is consistent with the male childhood peak. In
females, a small peak of ovarian germ cell cancers was
present in children in our data, but numbers were insufficient
to be confident that it is real. Analyses of other germ cell
cancer datasets may clarify this issue.
Gonadotropins might relate to germ cell malignancies in
two ways. First, prolonged stimulation by these hormones
causes ovarian tumourigenesis in animals (Murphy &
Beamer, 1973) and might have a similar role in humans.
Second, gonadotropins might promote the multiplication of
cells that have already suffered malignant transformation
(Henderson, 1982). The initiation of malignancy might occur
from prenatal hormone exposure (Walker et al., 1988): it is
notable that the adult peak closely resembles the incidence
curve of vaginal adenocarcinoma resulting from maternal
exposure to diethylstilboestrol (DES) (Herbst et al., 1971).
Inter-country variations in testicular cancer rates are
mainly a result of differences in the adult peak (Swerdlow,
1985). Very few data are available to determine whether the
same is true for germ cell cancer in females. The US Third
National Cancer Survey 1969-71 (Weiss et al., 1977) shows
an age curve similar in rates and shape to the present one
from England. In Los Angeles (Walker et al., 1984), the
overall incidence is higher than in England, with the excess
accounted for by a more prominent young age peak, and
rates at older ages indeed lower than in England. Data on
ovarian cancer incidence in Cancer Incidence in Five Con-
tinents are only available by histology in Volume II (Doll et
al., 1970), and for most registries analysis is not possible
because of very small numbers. In Sweden, 1962-65, the
overall incidence is higher than in our data (age-standardised
incidence rate of 3.72 per million per annum); there is a
bimodal distribution, with rates higher than in England in all
age-groups particularly older ages. Aggregating data for the
four English registries included in that publication (Doll et
al., 1970), showed age-specific rates similar at both age peaks
to the ones reported in the present data.
Perhaps variations in the use of postmenopausal oestrogen
replacement therapy and in prevalence of oophorectomy
might have contributed to the differences between popula-
tions in ovarian germ cell cancer risk at older ages, and the
secular decrease in incidence observed in our data for women
aged 45 years and over. Noncontraceptive oestrogens reduce
the elevated gonadotropin plasma levels characteristic of
postmenopausal women (Cooke et al., 1976). It would appear
worthwhile to investigate further the relation of gonadal
germ cell cancers in each sex with gonadotropin levels and
with administration of exogenous hormones, notably hor-
mone replacement therapy, which affect gonadotropin levels,
and with age at menarche and menopause.
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